Pamrevlumab
Pamrevlumab (also known as FG-3019) is an experimental drug developed by FibroGen for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy. It is a human monoclonal antibody that inhibits the activity of connective tissue growth factor (CTGF), a common factor in chronic fibrotic diseases and cancer.
Mechanism of Action[edit | edit source]
Pamrevlumab works by binding to and inhibiting the activity of CTGF, a protein that is overexpressed in many fibrotic diseases and cancers. By blocking the activity of CTGF, pamrevlumab can potentially slow down or halt the progression of these diseases.
Clinical Trials[edit | edit source]
Pamrevlumab has undergone several clinical trials for different indications. In a Phase 2 trial for idiopathic pulmonary fibrosis, the drug showed a significant reduction in disease progression compared to placebo. It is currently in Phase 3 trials for this indication.
For pancreatic cancer, pamrevlumab has shown promise in combination with gemcitabine and nab-paclitaxel in a Phase 2 trial. The drug is also in Phase 2 trials for Duchenne muscular dystrophy.
Potential Side Effects[edit | edit source]
As with any drug, pamrevlumab may cause side effects. These can include nausea, vomiting, diarrhea, and fatigue. However, the severity and frequency of these side effects can vary among individuals.
See Also[edit | edit source]
- FibroGen
- Idiopathic pulmonary fibrosis
- Pancreatic cancer
- Duchenne muscular dystrophy
- Connective tissue growth factor
- Clinical trial
| Pamrevlumab Resources | |
|---|---|
 |
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
